Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

Prof. Hiddo Heerspink: Insights from DAPA-CKD

01 Sep 2020

Description

In this special edition episode of the Endocrine Outlook, you will hear from Professor Hiddo Heerspink.  Heerspink recently presented results of the DAPA-CKD trial at the European Society of Cardiology examining the effects of dapagliflozin (Farxiga) in patients with chronic kidney disease with and without type 2 diabetes. This episode further explores the study and how its results inform the use of dapagliflozin in patients with and without type 2 diabetes.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.